Evidence map›Paper›PMID 36041862›Full record

ArticleMolecular pharmacology2022

Pore opening, not voltage sensor movement, underpins the voltage-dependence of facilitation by a hERG blocker.

Kazuharu Furutani, Ryotaro Kawano, Minami Ichiwara, Ryo Adachi, Colleen E Clancy, Jon T Sack, Satomi Kita

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. A hERG Blocker Facilitates KbioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Kazuharu FurutaniDepartment of Pharmacology, Tokushima Bunri University, Japan furutani@ph.bunri-u.ac.jp.ORCID 0000-0002-9680-2205
Ryotaro KawanoDepartment of Pharmacology, Tokushima Bunri University, Japan.
Minami IchiwaraDepartment of Pharmacology, Tokushima Bunri University, Japan.
Ryo AdachiDepartment of Pharmacology, Tokushima Bunri University, Japan.
Colleen E ClancyUC Davis School of Medicine, United States.
Jon T SackUC Davis School of Medicine, United States.
Satomi KitaDepartment of Pharmacology, Tokushima Bunri University, Japan.
University of California, Davis · US

Funding

In silico Safety PharmacologyR01HL128537 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CLANCY, COLLEEN E, SANTANA, LUIS F · 2016 to 2024
$5.7M
Predictive multiscale in silico cardio-pharmacologyU01HL126273 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CLANCY, COLLEEN E · 2015 to 2019
$3.8M
NHLBI NIH HHS R01 HL128537NHLBI NIH HHS U01 HL126273
6 · The paper itself

Abstract

A drug that blocks the cardiac myocyte voltage-gated K

Indexed as

antiarrhythmic drugselectrophysiologyhERGPotassium channelsvoltage-gated potassium channels

Identifiers

PMID36041862
PMCPMC9595204
OpenAlexW4293900900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.